Stocks
IGM Biosciences (IGMS) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -77.8 | -157.4 | -221.9 | -255.2 | -199.5 | -31.3 | ||
| Changes by years, y/y, % | +91% | +102% | +41% | +15% | -22% | +37.4% | |||
IGM Biosciences. EBITDA US GAAP, bln rub
IGM Biosciences. EBITDA US GAAP, changes, %
IGM Biosciences. EBITDA US GAAP, sum by quarters, bln rub
IGM Biosciences (IGMS) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -49.1 | -62.1 | -36.6 | -30.6 | 98.0 | -31.3 | |
| Changes by years, y/y, % | -26% | -4% | -42% | -41% | -300% | |||
| Changes by quarters, q/q, % | -5% | +26% | -41% | -16% | -420% | |||
